With that, let me turn the call over to Darren who will provide more detail on our first quarter performance as well as ...

PRESS RELEASE AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2040 THIS DECISION STRENGTHENS MASITINIB’S ...

2-Year U.S. Treasury Note Continuous Contract $104.293 0.000 0.00% 5-Year U.S. Treasury Note Continuous Contract $109.172 0.016 0.01% 10-Year U.S. Treasury Note Continuous Contract $112.359 0.063 0.06 ...

2-Year U.S. Treasury Note Continuous Contract $104.293 0.000 0.00% 5-Year U.S. Treasury Note Continuous Contract $109.180 0.023 0.02% 10-Year U.S. Treasury Note Continuous Contract $112.344 0.047 0.04 ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...